Boehringer Ingelheim (BI) and Qualcomm, a San Diego-based wireless technologies company, have formed a collaboration to develop a connectivity solution for BI's Respimat inhaler, the company's platform inhaler for its…
Takeda To Receive $312 Million In Zika Funding From US Government
Takeda Pharmaceutical Company has been selected by the US Biomedical Advanced Research and Development Authority (BARDA) to develop a vaccine in support of Zika response efforts in the US and…
Cambrex To Invest $9 Million to Expand API Manufacturing
Cambrex plans to invest SEK 72 million ($9 million) to expand large-scale manufacturing capacity for active pharmaceutical ingredients (API) at its facility in Karlskoga, Sweden. The investment includes the installation…
LI-COR To Provide Contract Manufacturing For Early-Phase Materials
LI-COR, a provider of systems for plant research, gas analysis, drug discovery, and protein research, is building on its expertise in reagent and dye production to expand its services to…
Evonik reports that th Medicines and Healthcare Products Regulatory Agency (MHRA), the UK’s national regulatory authority, renewed the company’s European Union (EU) GMP certification for Evonik Birmingham Laboratories in Alabama.…
Gerresheimer Group, a provider of special glass and plastic pharmaceutical packaging products, has modernized its plastic packaging operations at three of its facilities in Brazil. The three Brazilian production facilities…
CordenPharma’s French Facility Passes FDA Inspection
CordenPharma reports its CordenPharma Chenôve (France) manufacturing facility recently completed an inspection by the US Food and Drug Administration (FDA) and received a successful response with no 483s reported. The…
The European Commission has approved Pfizer’s Xalkori (crizotinib, a kinase inhibitor, for the treatment of adults with ROS1-positive advanced non-small cell lung cancer (NSCLC). Xalkori was previously approved in the…
Perrigo Gets Tentative FDA Approval For Generic Acne Drug
Perrigo Company has received tentative approval from the US Food and Drug Administration for the generic version of Epiduo Gel (adapalene and benzoyl peroxide 0.1%/2.5%), a drug to treat acne…
FDA Extends Review Of Novo Nordisk’s Diabetes Combo Therapy
The US Food and Drug Administration (FDA) has extended the review period for Novo Nordisk’s IDegLira, a fixed-ratio combination of insulin degludec and liraglutide in adults with Type 2 diabetes.…